JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB219650

Anti-PRAME 抗体 [EPR20330]

Anti-PRAME antibody [EPR20330]

Be the first to review this product! Submit a review

|

(26 Publications)

Anti-PRAME antibody [EPR20330] (ab219650) is a rabbit monoclonal antibody detecting PRAME in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human.

- Clone EPR20330 is the most cited clone to PRAME
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications

別名を表示する

MAPE, OIP4, PRAME, Melanoma antigen preferentially expressed in tumors, Opa-interacting protein 4, Preferentially expressed antigen of melanoma, OIP-4

16 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)

Immunohistochemical analysis of paraffin-embedded human melanoma tissue labeling PRAME with ab219650 at 1/500 dilution, followed by LeicaDS9800 (Bond™ Polymer Refine Detection). Sections were counter stained with Hematoxylin. Antigen retrieval was heat mediated with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. Nuclear staining on human melanoma. The section was incubated with ab219650 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Secondary antibody only control : Used PBS instead of primary antibody.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)

Immunohistochemical analysis of paraffin-embedded human stomach tissue labeling PRAME with ab219650 at 1/500 dilution, followed by LeicaDS9800 (Bond™ Polymer Refine Detection). Sections were counter stained with Hematoxylin. Antigen retrieval was heat mediated with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. Negative control : No staining on human stomach. The section was incubated with ab219650 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)

Tissue microarray (TMA) analysis using PRAME EPR20330 (ab219650).

Click here to view EPR20330 staining performance on human normal and cancer tissue microarray (TMA).

This table provides a detailed overview of positive PRAME staining (tick mark) and negative PRAME staining (cross mark) per sample type tested. PRAME is expressed in metastatic melanoma (PMID : 30045064). PRAME has low or no expression in normal tissues except in testis, ovary, placenta, adrenals and endometrium (PMID : 30045064).

The sections were pre-treated using Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). The sections were incubated with ab219650 at +4°C overnight followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer).

Flow Cytometry (Intracellular) - Anti-PRAME antibody [EPR20330] (AB219650)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-PRAME antibody [EPR20330] (AB219650)

PRAME flow cytometry with PRAME antibody ab219650 of 4% paraformaldehyde-fixed and 90% Methanol-permeabilised MeWo (Human malignant melanoma cell line) cells labeling PRAME with ab219650 at 1/500 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Flow Cytometry (Intracellular) - Anti-PRAME antibody [EPR20330] (AB219650)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-PRAME antibody [EPR20330] (AB219650)

Flow cytometry overlay histogram showing left K562 positive cells and right negative HEK293 stained with ab219650 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilised with 0.1 % PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab219650) (1x 106 in 100μl at 0.008μg/ml (1/267500 dilution)) for 30min at 22°C.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C.

Isotype control antibody (black line) was Recombinant Rabbit IgG monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.

Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.

This antibody gave a positive signal in K562 Fixed with 80% methanol (5 min) / permeabilised with 0.1 % PBS-Triton X-100 for 15 min under the same conditions.

Western blot - Anti-PRAME antibody [EPR20330] (AB219650)
  • WB

Supplier Data

Western blot - Anti-PRAME antibody [EPR20330] (AB219650)

PRAME western blot with PRAME antibody ab219650.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-PRAME antibody [EPR20330] (ab219650) at 1/1000 dilution

All lanes:

MeWo (Human malignant melanoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/4000 dilution

Predicted band size: 57 kDa

Observed band size: 57 kDa

false

Exposure time: 15s

Immunocytochemistry/ Immunofluorescence - Anti-PRAME antibody [EPR20330] (AB219650)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-PRAME antibody [EPR20330] (AB219650)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized MeWo (Human malignant melanoma cell line) cells labeling PRAME with ab219650 at 1/500 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing mostly nuclear staining on MeWo cells.

The nuclear counter stain is DAPI (blue). Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.

Immunocytochemistry/ Immunofluorescence - Anti-PRAME antibody [EPR20330] (AB219650)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-PRAME antibody [EPR20330] (AB219650)

PRAME immunofluorescence with PRAME antibody ab219650 in K562 cells with negative expression in Ramos cells. The cells were fixed with 4% formaldehyde (10 min) permeabilised with 0.1% Triton x-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab219650 at 1 μg/ml and ab7291 Mouse monoclonal [DM1A] to alpha Tubulin at 0.5 μg/ml. Cells were then incubated with ab150081 Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) pre-adsorbed at 1/1000 dilution (shown in green) and ab150119 Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 647) pre-adsorbed at 1/1000 dilution (shown in red). Nuclear DNA was labelled with DAPI (shown in blue).

Image was acquired with a confocal microscope (Leica-Microsystems TCS SP8) and a single confocal section is shown.

This product also work with 100% methanol (5 min) fixation under the same testing conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling PRAME with ab219650 at 1/500 dilution, followed by LeicaDS9800 (Bond™ Polymer Refine Detection). Sections were counter stained with Hematoxylin. Antigen retrieval was heat mediated with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. Negative control : No staining on human tonsil. The section was incubated with ab219650 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunocytochemistry/ Immunofluorescence - Anti-PRAME antibody [EPR20330] (AB219650)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-PRAME antibody [EPR20330] (AB219650)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized A-375 (Human malignant melanoma cell line) cells labeling PRAME with ab219650 at 1/500 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing mostly nuclear staining on A-375 cells.

The nuclear counter stain is DAPI (blue). Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)

Immunohistochemical analysis of paraffin-embedded human breast tissue labeling PRAME with ab219650 at 1/500 dilution, followed by LeicaDS9800 (Bond™ Polymer Refine Detection). Sections were counter stained with Hematoxylin. Antigen retrieval was heat mediated with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. Negative control : No staining on human breast. The section was incubated with ab219650 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue labeling PRAME with ab219650 at 1/500 dilution, followed by LeicaDS9800 (Bond™ Polymer Refine Detection). Sections were counter stained with Hematoxylin. Antigen retrieval was heat mediated with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. Nuclear staining on human breast carcinoma. The section was incubated with ab219650 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Secondary antibody only control : Used PBS instead of primary antibody.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRAME antibody [EPR20330] (AB219650)

Immunohistochemical analysis of paraffin-embedded human testis tissue labeling PRAME with ab219650 at 1/500 dilution, followed by LeicaDS9800 (Bond™ Polymer Refine Detection). Sections were counter stained with Hematoxylin. Antigen retrieval was heat mediated with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. Nuclear staining on human testis. The section was incubated with ab219650 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Secondary antibody only control : Used PBS instead of primary antibody.

Immunoprecipitation - Anti-PRAME antibody [EPR20330] (AB219650)
  • IP

Supplier Data

Immunoprecipitation - Anti-PRAME antibody [EPR20330] (AB219650)

PRAME was immunoprecipitated from 0.35 mg of MeWo (Human malignant melanoma cell line) whole cell lysate with ab219650 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab219650 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : MeWo whole cell lysate 10 μg (Input).

Lane 2 : ab219650 IP in MeWo whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab219650 in MeWo whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 1 second.

All lanes:

Immunoprecipitation - Anti-PRAME antibody [EPR20330] (ab219650)

Predicted band size: 57 kDa

false

Western blot - Anti-PRAME antibody [EPR20330] (AB219650)
  • WB

Supplier Data

Western blot - Anti-PRAME antibody [EPR20330] (AB219650)

PRAME western blot with PRAME antibody ab219650.

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1 : 3 minutes; Lane 2 : 5 seconds; Lane 3 : 1 minute.

All lanes:

Western blot - Anti-PRAME antibody [EPR20330] (ab219650) at 1/1000 dilution

Lane 1:

Human ovary cancer lysate at 20 µg

Lane 2:

A-375 (Human malignant melanoma cell line) whole cell lysate at 20 µg

Lane 3:

Human testis lysate at 20 µg

Secondary

All lanes:

Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution

Predicted band size: 57 kDa

Observed band size: 57 kDa

false

Western blot - Anti-PRAME antibody [EPR20330] (AB219650)
  • WB

Lab

Western blot - Anti-PRAME antibody [EPR20330] (AB219650)

PRAME western blot with PRAME antibody ab219650.

Different batches of ab219650 were tested on MeWo (Human malignant melanoma fibroblast) whole cell lysate at 0.1 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 50 kDa.

All lanes:

Western blot - Anti-PRAME antibody [EPR20330] (ab219650)

Predicted band size: 57 kDa

false

関連する標識済み抗体及び組成の異なる製品 (5)

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR20330

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

Flow Cyt (Intra), IP, WB, ICC/IF, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

PRAME is expressed in malignant cells, including leukaemias, Hodgkin's lymphoma, breast cancer, and primary and metastatic melanomas.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p>Recommend ab219650 incubation at +4°C overnight.</p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

下記製品にもご興味をお持ちいただけるかもしれません:

AB315808

Anti-GPCR GPRC5D antibody [EPR28376-41]

0

0 Reviews

製品ページを見る
こちらの製品も推奨する理由

この製品は、同様の実験や関連する研究で広く使用されていることから推奨させていただいております。

お客様の実験に適するかご確認いただくため、必ず製品データシートをご確認いただくことをお勧めいたします。ご不明点等ございましたら、テクニカルサポートチームまでお問い合わせください。

製品の詳細

Anti-PRAME antibody [EPR20330] (ab219650) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, IP and WB.

Abcam's high quality manufacturing and validation processes ensure Anti-PRAME antibody [EPR20330] (ab219650) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

Anti-PRAME antibody [EPR20330] (ab219650) specifically detects PRAME (UniProt ID: P78395; Molecular weight: 58kDa) and is sold in 100 µL and 1 mL selling sizes.

Conjugation-ready, carrier free format available for antibody clone EPR20330 - ab232571.

Antibody clone EPR20330 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 555, Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 594 (ab307626, ab307630, ab307769, ab312896).

This top cited antibody is highly specific for PRAME, a protein that is highly expressed in different types of cancers and is involved in cell proliferation and metastasis, as well as the outcomes of patients with cancer.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

PRAME or Preferentially Expressed Antigen in Melanoma is a cancer/testis antigen with a molecular mass of approximately 57 kDa. The PRAME protein is expressed in various tumors including melanoma and shows limited expression in normal adult tissues. Researchers use Monoclonal Antibody EPR20330 to detect PRAME due to its specificity and reliability in applications like PRAME immunohistochemistry (IHC).
Biological function summary

The PRAME protein influences cell proliferation and apoptosis by acting as a repressor of retinoic acid signaling. It is not part of a large complex but interacts with proteins involved in retinoic acid pathways. PRAME inhibits retinoic acid receptor signaling leading to disrupted cell differentiation and survival which is advantageous for cancer cells.

Pathways

Studies show the involvement of PRAME in important cellular processes. It plays a significant role in the retinoic acid pathway and interacts with retinoic acid receptors RAR and RXR. By inhibiting these receptors PRAME affects the transcriptional activity and cellular responses typically mediated by retinoic acid contributing to tumor growth and cancer cell survival.

PRAME expression correlates with aggressive forms of melanoma and various other malignancies such as lung cancer. The presence of PRAME serves as a marker for poor prognosis and can indicate a more invasive cancer phenotype. In melanoma PRAME interacts with proteins related to the disease's progression further emphasizing its importance as a target for therapeutic strategies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

The protein expressed by gene PRAME functions as a transcriptional repressor, inhibiting retinoic acid signaling through retinoic acid receptors RARA, RARB, and RARG. It prevents retinoic acid-induced cell proliferation arrest, differentiation, and apoptosis. This supplementary information is collated from multiple sources and compiled automatically.
See full target information PRAME

文献 (26)

Recent publications for all applications. Explore the full list and refine your search

Journal of cancer research and clinical oncology 149:15003-15011 PubMed37610673

2023

Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets.

Applications

IHC-P

Species

Human

Jie Xiao,Fengli Huang,Lin Li,Lianru Zhang,Li Xie,Baorui Liu

Journal of cutaneous pathology 50:1001-1005 PubMed37565491

2023

PRAME-negativity in sclerosing nevi with pseudomelanomatous features supports classification as an indolent lesion.

Applications

Unspecified application

Species

Unspecified reactive species

Haiming Tang,Jennifer M McNiff,Earl J Glusac,Christine Ko

Cancers 15: PubMed37173882

2023

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Viola Hedrich,Kristina Breitenecker,Gregor Ortmayr,Franziska Pupp,Heidemarie Huber,Doris Chen,Sarthak Sahoo,Mohit Kumar Jolly,Wolfgang Mikulits

Open medicine (Warsaw, Poland) 18:20230665 PubMed36910848

2023

HDAC5-mediated PRAME regulates the proliferation, migration, invasion, and EMT of laryngeal squamous cell carcinoma via the PI3K/AKT/mTOR signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Yu,Huan Cao,Jian-Wang Yang,Wen-Xia Meng,Chuan Yang,Jian-Tao Wang,Miao-Miao Yu,Bao-Shan Wang

International journal of molecular sciences 24: PubMed36768616

2023

Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens.

Applications

Unspecified application

Species

Unspecified reactive species

Paul Schossig,Ebru Coskun,Ruza Arsenic,David Horst,Jalid Sehouli,Eva Bergmann,Nadine Andresen,Christian Sigler,Antonia Busse,Ulrich Keller,Sebastian Ochsenreither

Pathology international 73:27-36 PubMed36468840

2022

Performance of PRAME immunohistochemistry compared with that of c-Kit, c-Myc, or cyclin D1 for the diagnosis of acral melanocytic tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Joon Min Jung,Mi Young Lee,Chong Hyun Won,Sung Eun Chang,Mi Woo Lee,Woo Jin Lee

Histopathology 82:285-295 PubMed36200756

2022

PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics.

Applications

Unspecified application

Species

Unspecified reactive species

Yan-Ping Chen,Wen-Wen Zhang,Ya-Ting Qiu,Long-Feng Ke,Hao Chen,Gang Chen

Histopathology 81:808-817 PubMed36094779

2022

Hyperplastic melanocytes with chromosomal aberrations in surrounding skin of subungual melanoma: fluorescence in situ hybridisation analysis using whole-slide digital imaging.

Applications

Unspecified application

Species

Unspecified reactive species

Naoko Shojiguchi,Sayaka Takai,Eiichi Arai

Journal of cutaneous pathology 49:709-716 PubMed35488519

2022

PRAME immunohistochemistry of spitzoid neoplasms.

Applications

Unspecified application

Species

Unspecified reactive species

Stephen S Koh,Sean K Lau,Jason V Scapa,David S Cassarino

Diagnostic pathology 17:41 PubMed35484605

2022

Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit.

Applications

Unspecified application

Species

Unspecified reactive species

Young Jae Kim,Chang Jin Jung,Hyoungmin Na,Woo Jin Lee,Sung Eun Chang,Mi Woo Lee,Chan-Sik Park,Youngkyoung Lim,Chong Hyun Won
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。
enhancedValidationDataWebsite
en

関連製品

Select an associated product type
Alternative Product
Primary Antibodies

AB89097

Anti-PRAME antibody

primary-antibodies

prame-antibody-ab89097

4

(1 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com